Literature DB >> 11390563

Positron emission mammography-guided breast biopsy.

R R Raylman1, S Majewski, A G Weisenberger, V Popov, R Wojcik, B Kross, J S Schreiman, H A Bishop.   

Abstract

UNLABELLED: Positron emission mammography (PEM) is a technique to obtain planar images of the breast for detection of potentially cancerous, radiotracer-avid tumors. To increase the diagnostic accuracy of this method, use of minimally invasive methods (e.g., core biopsy) may be desirable for obtaining tissue samples from lesions detected with PEM. The purpose of this study was to test the capabilities of a novel method for performing PEM-guided stereotactic breast biopsies.
METHODS: The PEM system consisted of 2 square (10 x 10 cm) arrays of discrete scintillator crystals. The detectors were mounted on a stereotactic biopsy table. The stereotactic technique used 2 PEM images acquired at +/-15 degrees and a new trigonometric algorithm. The accuracy and precision of the guidance method was tested by placement of small point sources of (18)F at known locations within the field of view of the imager. The calculated positions of the sources were compared with the known locations. In addition, simulated stereotactic biopsies of a breast phantom consisting of a 10-mm-diameter gelatin sphere containing a concentration of (18)F-FDG consistent with that reported for breast cancer were performed. The simulated lesion was embedded in a 4-cm-thick slab of gelatin containing a commonly reported concentration of FDG, simulating a compressed breast (target-to-background ratio, approximately 8.5:1). An anthropomorphic torso phantom was used to simulate tracer uptake in the organs of a patient 1 h after a 370-MBq injection of FDG. Five trials of the biopsy procedure were performed to assess repeatability. Finally, a method for verifying needle positioning was tested.
RESULTS: The positions of the point sources were successfully calculated to within 0.6 mm of their true positions with a mean error of +/-0.4 mm. The biopsy procedures, including the method for verification of needle position, were successful in all 5 trials in acquiring samples from the simulated lesions.
CONCLUSION: The success of this new technique shows its potential for guiding the biopsy of breast lesions optimally detected with PEM.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390563

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

1.  Oncologic positron emission tomography: a surgical perspective.

Authors:  Todd O Moore; Landis K Griffeth
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-01

2.  Incorporation of preprocedural PET into CT-guided radiofrequency ablation of hepatic metastases: a nonrigid image registration validation study.

Authors:  Peng Lei; Omkar Dandekar; David Widlus; Raj Shekhar
Journal:  J Digit Imaging       Date:  2009-05-27       Impact factor: 4.056

3.  Design considerations for a limited angle, dedicated breast, TOF PET scanner.

Authors:  S Surti; J S Karp
Journal:  Phys Med Biol       Date:  2008-05-06       Impact factor: 3.609

Review 4.  Advantages and limitations of FDG PET in the follow-up of breast cancer.

Authors:  Peter Lind; Isabel Igerc; Thomas Beyer; Peter Reinprecht; Klaus Hausegger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-15       Impact factor: 9.236

5.  Diagnostic performance of a novel high-resolution dedicated axillary PET system in the assessment of regional nodal spread of disease in early breast cancer.

Authors:  Jingyi Cheng; Junjie Li; Guangyu Liu; Ruohong Shui; Sheng Chen; Benlong Yang; Zhimin Shao
Journal:  Quant Imaging Med Surg       Date:  2022-02

6.  Initial Experience with a Cone-beam Breast Computed Tomography-guided Biopsy System.

Authors:  Posy J Seifert; Renee C Morgan; David L Conover; Andrea L Arieno
Journal:  J Clin Imaging Sci       Date:  2017-01-27

7.  Influence of the presence of tissue expanders on energy deposition for post-mastectomy radiotherapy.

Authors:  Débora M Trombetta; Simone C Cardoso; Alessandro Facure; Ademir X da Silva; Luiz Antonio R da Rosa
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.